Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 6/20 | 1.00 |
| ▸ | RORC | P51449 | 5/20 | 1.00 |
| ▸ | OSBP2 | Q969R2 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.85 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.85 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.84 |
| ▸ | CRYAB | P02511 | 1/20 | 0.80 |
| ▸ | HMGCR | P04035 | 1/20 | 0.80 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.80 |
| ▸ | ITGAV | P06756 | 1/20 | 0.80 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.80 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.80 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.80 |
| ▸ | DHCR24 | Q15392 | 1/20 | 0.77 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.75 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cholesterol SCHEMBL21707472 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL21539517 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL22095727 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL21447271 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL23579652 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL21340667 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL23365796 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL21650234 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL23761109 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA | |
| Cholesterol SCHEMBL21445079 | 1.00 | OSBP (1.00) | OSBPRORCOSBP2USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4301138-A2 | TUMOR STORAGE AND CELL CULTURE COMPOSITIONS | Iovance Biotherapeutics, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| CN-117279506-A | Tumor storage and cell culture compositions | 艾欧凡斯生物治疗公司 | 2023-12-22 | — | — | CN | claimed |
| WO-2022187741-A2 | TUMOR STORAGE AND CELL CULTURE COMPOSITIONS | IOVANCE BIOTHERAPEUTICS, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260124139-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | DIASOME PHARMACEUTICALS INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4308248-B1 | COSMETIC SKIN CARE COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-05-06 | — | — | EP | disclosed |
| US-20250387196-A1 | SEGMENTAL OSCILLATION TOOL AND LUBRICANT | FLORMAN MICHAEL J (US) | 2025-12-25 | — | — | US | disclosed |
| EP-3503866-B1 | COMPOSITIONS COMPRISING ISOHEXIDE DIESTERS OF C18 FATTY ACIDS AND THEIR USE IN METHODS FOR RESTORING EPIDERMAL INTEGRITY AND FUNCTION AND TREATING DERMATOLOGICAL DISEASES | SYTHEON LTD (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4251220-B1 | BIOCOMPATIBLE ORGANOGEL MATRICES FOR PREPARATION OF A DRUG DELIVERY DEPOT | DEPUY SYNTHES PRODUCTS INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | DIASOME PHARMACEUTICALS INC (US) | 2025-09-18 | — | — | US | disclosed |
| US-12364430-B2 | Wearable device for continuous monitoring of user health for accurate clinical outcomes and wellness programs | KURANI HETAL B (US) | 2025-07-22 | — | — | US | disclosed |
| US-20070218117-A1 | Supra molecular construct for delivery of interferon to a mammal | SDG, INC. | 2007-09-20 | — | — | US | disclosed |
| EP-1465933-B1 | POLYMER CONJUGATES | BIOCOMPATIBLES UK LTD (GB) | 2007-08-29 | — | — | EP | disclosed |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | FURGESON DARIN Y | 2007-07-05 | — | — | US | disclosed |
| EP-0954317-B1 | USE OF 7 APHA-SUBSTITUTED STEROIDS TO TREAT NEUROPSYCHIATRIC DISORDERS | UNIV EDINBURGH (GB) | 2007-06-06 | — | — | EP | disclosed |
| US-20070116653-A1 | Hair treatment compositions | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2007-05-24 | — | — | US | disclosed |
| US-20070088014-A1 | OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES | ALLERGAN, INC. (US) | 2007-04-19 | — | — | US | disclosed |
| US-7183263-B2 | Linear polyethylenimine-sterol conjugates for gene delivery | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2007-02-27 | — | — | US | disclosed |
| US-20070042970-A1 | Folate-modified cholesterol-bearing pullulan as a drug carrier | CHEMICAL SOFT R&D INC. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-7170575-B2 | Homeotropically aligned liquid crystal layer and process for the homeotropic alignment of liquid crystals on plastic substrates | MERCK PATENT GMBH (DE) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070218117-A1 | Supra molecular construct for delivery of interferon to a mammal | HAVCR2, IFNAR1, MSR1 | OSBP 220/4885RORC 243/4885OSBP2 496/4885 |
| US-20070088014-A1 | OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES | SERPINA6, NR3C1, PDE6C | OSBP 599/4885RORC 184/4885OSBP2 429/4885 |
| US-20070042970-A1 | Folate-modified cholesterol-bearing pullulan as a drug carrier | CETP, EPHA2, FOLR2 | OSBP 1428/4885RORC 2890/4885OSBP2 1175/4885 |
| US-20250288521-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, FABP6 | OSBP 209/4885RORC 3284/4885OSBP2 604/4885 |
| US-20260137621-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | FABP2, FABP1, SGMS2 | OSBP 134/4885RORC 3851/4885OSBP2 295/4885 |
| US-20260124139-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | GPR119, INSR, FABP1 | OSBP 451/4885RORC 1229/4885OSBP2 926/4885 |
| US-20070154447-A1 | Linear polyethylenimine-sterol conjugates for gene delivery | LDLR, CETP, CYP11A1 | OSBP 227/4885RORC 1925/4885OSBP2 103/4885 |
| US-20070116653-A1 | Hair treatment compositions | CKMT1A; CKMT1B, CRAT, CPT2 | OSBP 3776/4885RORC 3092/4885OSBP2 3962/4885 |
| US-20250387196-A1 | SEGMENTAL OSCILLATION TOOL AND LUBRICANT | DVL1, DVL3, SHH | OSBP 1923/4885RORC 2631/4885OSBP2 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.